Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases

Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases

US Patent 8287874 · Granted Oct 16, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-VLA-4 related assays2025
CD19 variants2024
Compositions and methods for treatment of cancer2023
Anti-VLA-4 related assays2022
Targeted cancer therapy2021
Compositions and methods for tumor transduction2021
Compositions and methods for treatment of cancer2020
Compositions and methods for treatment of cancer2019
Methods of modulating immune responses using BCMA polypeptide2019
Methods of modulating immune responses using BCMA polypeptide2019
Anti-VLA-4 related assays2019
Compositions and methods for tumor transduction2018